Lion Chemtech Balance Sheet Health
Financial Health criteria checks 5/6
Lion Chemtech has a total shareholder equity of ₩128.0B and total debt of ₩17.0B, which brings its debt-to-equity ratio to 13.3%. Its total assets and total liabilities are ₩153.3B and ₩25.4B respectively. Lion Chemtech's EBIT is ₩7.0B making its interest coverage ratio -4.5. It has cash and short-term investments of ₩40.2B.
Key information
13.3%
Debt to equity ratio
₩17.00b
Debt
| Interest coverage ratio | -4.5x |
| Cash | ₩40.20b |
| Equity | ₩127.96b |
| Total liabilities | ₩25.38b |
| Total assets | ₩153.34b |
Recent financial health updates
Recent updates
These Return Metrics Don't Make Lion Chemtech (KOSDAQ:171120) Look Too Strong
Dec 09
We Think That There Are More Issues For Lion Chemtech (KOSDAQ:171120) Than Just Sluggish Earnings
Sep 08Lion Chemtech (KOSDAQ:171120) Seems To Use Debt Rather Sparingly
Apr 05Can You Imagine How Lion Chemtech's (KOSDAQ:171120) Shareholders Feel About The 30% Share Price Increase?
Mar 12What Is The Ownership Structure Like For Lion Chemtech Co., Ltd. (KOSDAQ:171120)?
Feb 19Should You Be Adding Lion Chemtech (KOSDAQ:171120) To Your Watchlist Today?
Feb 01
Lion Chemtech Co., Ltd.'s (KOSDAQ:171120) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 12Should You Rely On Lion Chemtech's (KOSDAQ:171120) Earnings Growth?
Dec 22Would Shareholders Who Purchased Lion Chemtech's (KOSDAQ:171120) Stock Five Years Be Happy With The Share price Today?
Dec 03Financial Position Analysis
Short Term Liabilities: A171120's short term assets (₩76.2B) exceed its short term liabilities (₩25.3B).
Long Term Liabilities: A171120's short term assets (₩76.2B) exceed its long term liabilities (₩78.7M).
Debt to Equity History and Analysis
Debt Level: A171120 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A171120's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A171120's debt is well covered by operating cash flow (70.4%).
Interest Coverage: A171120 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 08:31 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lion Chemtech Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sang-Hun Lee | iM Securities |
| Sang Gyu Shim | Kyobo Securities Co., Ltd |